Glenmark gets final nod by USFDA to sell Rufinamide drug

Rufinamide is used to treat seizures caused by Lennox-Gastaut syndrome, it will be available as tablets in 200 mg and 400 mg strengths.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news